Barclays Issues Positive Forecast for Kenvue (NYSE:KVUE) Stock Price

Key Points

• Barclays raised its price target on Kenvue from $17 to $18 and kept an "equal weight" rating, implying roughly a 7.95% upside from the prior close.
• Kenvue reported quarterly EPS of $0.28 (beat by $0.01) on $3.76B revenue (below estimates) and set FY2025 EPS guidance of $1.00–$1.05, against analyst expectations near $1.14.
• The stock trades around $16.68 (down ~1.2%), the consensus analyst rating is a "Hold" with an average price target of $20.23, and institutional investors own about 97.6% of the shares.

Kenvue (NYSE:KVUE - Get Free Report) had its target price raised by equities researchers at Barclays from $17.00 to $18.00 in a research note issued to investors on Monday,Benzinga reports. The firm presently has an "equal weight" rating on the stock. Barclays's price target would suggest a potential upside of 7.95% from the stock's previous close.

Several other equities analysts have also issued reports on KVUE. Deutsche Bank Aktiengesellschaft set a $18.00 price target on Kenvue in a research note on Friday, October 24th. Evercore ISI set a $18.00 price target on shares of Kenvue in a report on Tuesday, October 28th. Bank of America cut their target price on Kenvue from $25.00 to $21.00 and set a "buy" rating on the stock in a research note on Wednesday, October 8th. Canaccord Genuity Group reiterated a "hold" rating and set a $15.00 target price (down from $26.00) on shares of Kenvue in a report on Wednesday, October 29th. Finally, Jefferies Financial Group reduced their target price on shares of Kenvue from $25.00 to $23.00 and set a "buy" rating for the company in a research note on Monday, October 27th. One investment analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, twelve have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus price target of $20.23.

Kenvue Stock Down 1.2%

Shares of KVUE stock traded down $0.21 during trading on Monday, hitting $16.68. 25,734,274 shares of the company were exchanged, compared to its average volume of 23,068,008. The firm has a market capitalization of $31.95 billion, a price-to-earnings ratio of 22.23, a P/E/G ratio of 2.46 and a beta of 0.71. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.69 and a current ratio of 0.98. The business's 50-day simple moving average is $16.76 and its 200 day simple moving average is $20.26. Kenvue has a twelve month low of $14.02 and a twelve month high of $25.17.

Kenvue (NYSE:KVUE - Get Free Report) last announced its quarterly earnings data on Monday, November 3rd. The company reported $0.28 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.27 by $0.01. The business had revenue of $3.76 billion during the quarter, compared to analyst estimates of $3.83 billion. Kenvue had a return on equity of 20.02% and a net margin of 9.55%.Kenvue's quarterly revenue was down 3.5% compared to the same quarter last year. During the same period last year, the company earned $0.28 earnings per share. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. As a group, analysts forecast that Kenvue will post 1.14 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of KVUE. Evergreen Wealth Solutions LLC boosted its position in shares of Kenvue by 2.6% during the 1st quarter. Evergreen Wealth Solutions LLC now owns 16,769 shares of the company's stock valued at $402,000 after acquiring an additional 432 shares during the last quarter. AlphaCore Capital LLC increased its position in Kenvue by 9.9% during the 2nd quarter. AlphaCore Capital LLC now owns 5,287 shares of the company's stock valued at $111,000 after purchasing an additional 476 shares during the period. Wealth Alliance LLC lifted its holdings in Kenvue by 1.6% during the first quarter. Wealth Alliance LLC now owns 31,778 shares of the company's stock worth $762,000 after buying an additional 486 shares during the period. Empirical Finance LLC increased its holdings in shares of Kenvue by 1.8% in the 2nd quarter. Empirical Finance LLC now owns 28,309 shares of the company's stock valued at $593,000 after acquiring an additional 491 shares during the period. Finally, Everett Harris & Co. CA raised its position in shares of Kenvue by 1.4% in the 1st quarter. Everett Harris & Co. CA now owns 36,971 shares of the company's stock worth $887,000 after acquiring an additional 500 shares in the last quarter. 97.64% of the stock is currently owned by institutional investors.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.